Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1309, doi. 10.1042/CS20190249
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2019 AND VI 133 AND IP 12
Results: 7
1
2
Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1321, doi. 10.1042/CS20190372
- By:
- Publication type:
- Article
3
Overexpression of the aryl hydrocarbon receptor nuclear translocator partially rescues fetoplacental angiogenesis in severe fetal growth restriction.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1353, doi. 10.1042/CS20190381
- By:
- Publication type:
- Article
4
Endothelin receptor antagonism during preeclampsia: a matter of timing?
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1341, doi. 10.1042/CS20190464
- By:
- Publication type:
- Article
5
G-CSF partially mediates bone loss induced by Staphylococcus aureus infection in mice.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1297, doi. 10.1042/CS20181001
- By:
- Publication type:
- Article
6
Association of functional variant in GDF1 promoter with risk of congenital heart disease and its regulation by Nkx2.5.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1281, doi. 10.1042/CS20181024
- By:
- Publication type:
- Article
7
Revisiting hypoxia therapies for tuberculosis.
- Published in:
- Clinical Science, 2019, v. 133, n. 12, p. 1271, doi. 10.1042/CS20190415
- By:
- Publication type:
- Article